Antu Bio and its wholly-owned subsidiary Antu Instrument recently obtained two medical device registration certificates issued by the Henan Medical Products Administration. The acquisition of these certificates further enriches the company's product menu, meets market demand, and effectively supplements existing testing products, which will gradually enhance the company's overall competitiveness. In the first quarter of 2026, Antu Bio achieved revenue of 992 million yuan and net profit attributable to the parent of 236 million yuan.
Autobio Diagnostics Co LtdObtained two medical device registration certificates from Henan Medical Products Administration, enriching product menu and enhancing competitiveness.